科指倒跌逾1% 京東健康及阿里健康吐7%-9%
晶片股美光(MU.US)展望勝預期,股價漲逾7%,同業受捧,帶動費城半導體指數昨晚急彈3.3%結束三連吐,加上權重科技股普遍漲逾1.5%-3%,帶動納指回升1.8%跑贏藍籌指數。此外,反映中概股表現金龍中國指數昨晚續升0.6%。然而,本港科指繼昨天飆近4.8%至4,341創逾一個月高遇壓收窄升幅後,今早高開最多升1.5%至4,310乏力,半日低收4,198,倒跌1.1%,結束兩連漲。恆指半日收20,053,倒跌138點或0.7%,半日總成交額近667億元。
30隻科指成份股逾三分二回吐;三大互聯網醫療股吐近4%-9.5%,阿里健康(00241.HK)及京東健康(06618.HK)沽壓最大,股價分別吐近9.5%及7%,半日收5.72及56.8元,股價均跌破10天及50天線。
百度(09888.HK)及屢創逾年半高金山軟件(03888.HK)回吐4.6%及3.6%,股價曾分別低見147.7元及38.6元。此外,閱文(00772.HK)由逾一年高位回吐4.5%曾低見42元。美團(03690.HK)及騰訊(00700.HK)反覆吐近1%。
然而,去年虧損收窄獲高盛升價至91元的快手(01024.HK)續升近5%曾越百天線(60.9元)高見61.9元。小鵬(09868.HK)及蔚來(09866.HK)續升3.4%-4.8%,股價曾分別高見44.05元及77.65元。阿里巴巴(09988.HK)續升不足1%曾高見97.2元(受制昨天盤中所造高位98元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.